CLINICAL_TRIALS
trial_result
· 2023-04-04
Clinical Trial Update: Adjunctive Ganaxolone Treatment (Part A) in TSC Followed by Long-term Treatment (Part B) [Phase 2]
Summary
Phase 2 clinical trial on adjunctive ganaxolone for tuberous sclerosis complex (TSC) completed with long-term treatment data posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Marinus Pharmaceuticals | Conditions: Tuberous Sclerosis | Phase 2 | Status: COMPLETED | Results posted: 2023-04-04